Skip to main content

Home/ health information/ Group items tagged AAH-Pharmaceutical

Rss Feed Group items tagged

pharmacybiz

Brain Chambers : AAH appoints as Chief Commercial Officer - 0 views

  •  
    AAH Pharmaceuticals (AAH) has announced the appointment of Brain Chambers as Chief Commercial Officer. "I'm proud to lead the commercial functions in AAH in my new role and broader area of responsibility." Said Brian. "I'm committed to delivering on great value for our customers and building and strengthening our supplier partnerships." Brain is associated with AAH Pharmaceuticals for more than 14 years. He joined the organisation as Business Development Manager in October 2008. His previous role in the organisation was on Sales and Marketing Director. He posted on LinkedIn: "This is a big move for me personally, but that's a side hustle. What is the main play here is AAH becoming a standalone independent wholesale business focussed on only the AAH customer and our core business and this is just one part of that.
pharmacybiz

AAH:Delivers 70 million COVID-19 vaccines across England - 0 views

  •  
    AAH Pharmaceuticals Ltd (AAH) has exceeded the milestone of delivering over 70 million COVID-19 vaccination doses across England, since it was awarded a contract in December 2020. In addition, AAH has delivered over 100 million ancillary items to more than 3,000 healthcare providers. David Bound, chief executive officer of AAH, said: "This is a huge milestone for AAH as we work tirelessly to support our communities. It's also a ringing endorsement of our delivery drivers, warehouse operatives, and specialist logistics teams and the determination, dedication, and passion they continue to show throughout this extraordinary period." The vaccination programme was also recognized by the Supply Chain Excellence Awards. Chris Emmott, senior project lead - Supply Chain, commented: "I'm incredibly proud that AAH was chosen for this job, particularly as we had the skills, the experience, and a great team to help facilitate the needs of the country. To get ready for a project like this, everybody's worked very long hours, they've worked weekends to get everything ready.
pharmacybiz

AAH Pharmaceuticals on sale again - 0 views

  •  
    Private equity firms HIG and Capvest have joined the list of investors who have expressed interest in acquiring AAH Pharmaceuticals - the biggest supplier of goods to British pharmacies. The company, which was bought by German private equity firm Aurelius in 2022, is once again up for sale, according to the Financial Times. Aurelius has hired advisers from BNP Paribas to run an auction process for the pharma giant, with the first round of indicative bids expected later this month, the report said. AAH Pharmaceuticals supplies a network of 14,000 pharmacies across the UK, generating £3bn a year in revenues. Aurelius anticipated that the business could fetch an enterprise value, including debt, of roughly 10 times its earnings, which were projected to be around £90 million this year. People familiar with the matter told the publication that the business has drawn interest from bidders because it was likely to be "the only full-service pharmacy distributor to come to market in the coming years." The auction process is expected to be completed by the end of the year, although Aurelius may decide not to sell the business if the offers do not meet their desired price, the report said.
pharmacybiz

AAH promotes David Bound to CEO - Latest Pharmacy News | Business | Magazine - Pharmacy... - 0 views

  •  
    AAH Pharmaceuticals on Tuesday (November 15) announced the promotion of its commercial director David Bound to chief executive officer of the company. In his 10 years in the company, Mr Bound has helped to drive growth across the AAH business, implementing new digital channels for customers, and developing strategic partnerships with pharmaceutical manufacturers - drawing on from his vast experience in the healthcare industry, as well as in supply chain, operations, and trading. Commenting on his promotion, he said: "I'm delighted to be taking on this role at such a critical time for healthcare. There are many challenges affecting the industry right now - from inflationary pressures to workforce issues - and I'm looking forward to tackling them head-on alongside my excellent team."
pharmacybiz

Complete skin protection in just easy steps - 0 views

  •  
    The Intime range from incontinence experts Ontex provides maximum protection and the low hipster waist has been designed with discretion and comfort in mind, absorbing eight times its own weight. The innovative hipster shape brings a perfect fit that works with any outfit, to provide a comfortable sensation and maximum wear-ability for the user. The slim core means that women will never feel a bulky sensation when wearing Intime. Prices start from £8.99 for a pack of 12 and can be purchased via the AAH ordering platform, or through your local AAH contact.
pharmacybiz

Aurelius completes acquisition of McKesson UK - 0 views

  •  
    European asset management group Aurelius has completed the acquisition of McKesson UK, marking the company's fifth completed transaction in a year. McKesson UK is the parent company of a number of healthcare businesses including LloydsPharmacy, John Bell & Croyden and AAH Pharmaceuticals. It comprises four divisions and holds a substantial market share across each vertical: retail, digital, homecare and wholesale. McKesson UK's success has been underpinned by its strong LloydsPharmacy brand, its customer base and its leading commercial footprint across wholesale pharmaceuticals. Over recent years, the company has benefited from the introduction of additional services delivered across its more than 1,300 pharmacies, a growing digital offering and the ability to support the increasing trend of primary care being delivered to patients in their home.
pharmacybiz

Hallo Healthcare : McKesson UK changes name - 0 views

  •  
    McKesson UK has announced that it has changed its name to Hallo Healthcare Group. This year, in April, European asset management group Aurelius completed the acquisition of McKesson UK. Over recent years, the company has benefited from the introduction of additional services delivered across its more than 1,300 pharmacies, a growing digital offering and the ability to support the increasing trend of primary care being delivered to patients in their home. On Monday, the company posted on LinkedIn: "Today we have officially changed our name from McKesson UK to Hallo Healthcare Group. This marks our separation from the McKesson Corporation and the start of our exciting new world under Aurelius Group ownership."
1 - 7 of 7
Showing 20 items per page